CliffBio
small molecule

ALKINDI SPRINKLE

HYDROCORTISONE

Loss of exclusivityMay 2034latest FDA-listed patent expiry
CompanyEton Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameALKINDI SPRINKLE
Active ingredientHYDROCORTISONE
Strength5MG
Dosage formGRANULE
RouteORAL
ModalitySmall molecule
FDA approvalSeptember 2020
Marketing statusRX

Listed patents

PatentExpiresType
9649280May 2034product
9675559January 2033use U-3075
9717740November 2032use U-3075

More from Eton Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

ALKINDI SPRINKLE patent cliff — loss of exclusivity May 2034 | CliffBio